EH
Eddie Hickman Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
12
Avg Return
Past Year
Past Year
334%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
91.7%
Neutral
8.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $90 |
25%
upside
| 3 | +15% |
0
%
| 25 Feb ‘26 13 days ago |
|
|
|
Buy
Maintained
| $35 |
54%
upside
| 3 | +1,186% |
0
%
| 6 Feb ‘26 1 month ago |
|
|
|
Buy
Initiated
| $11 |
163%
upside
| 1 | +15% |
0
%
| 20 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $48 |
741%
upside
| 2 | -11% |
0
%
| 3 Dec ‘25 3 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | -50% |
–
| 29 Aug ‘25 6 months ago |
|
|
|
Buy
Maintained
| $22 |
104%
upside
| 1 | +36% |
0
%
| 13 Mar ‘25 1 year ago |
|
|
|
Buy
Initiated
| $32 |
97%
upside
| 1 | +44% |
0
%
| 13 Mar ‘25 1 year ago |
|